Indian Journal of Medical Microbiology IAMM  | About us |  Subscription |  e-Alerts  | Feedback |  Login   
  Print this page Email this page   Small font sizeDefault font sizeIncrease font size
 Home | Ahead of Print | Current Issue | Archives | Search | Instructions  
Users Online: 1086 Official Publication of Indian Association of Medical Microbiologists 
  Search
 
 ~ Next article
 ~ Previous article 
 ~ Table of Contents
  
 ~  Similar in PUBMED
 ~  Search Pubmed for
 ~  Search in Google Scholar for
 ~  Article in PDF (218 KB)
 ~  Citation Manager
 ~  Access Statistics
 ~  Reader Comments
 ~  Email Alert *
 ~  Add to My List *
* Registration required (free)  

 
 ~  References

 Article Access Statistics
    Viewed2280    
    Printed133    
    Emailed0    
    PDF Downloaded240    
    Comments [Add]    
    Cited by others 2    

Recommend this journal

 


 
CORRESPONDENCE
Year : 2010  |  Volume : 28  |  Issue : 4  |  Page : 413-414
 

Increasing levels of minimum inhibitory concentration vancomycin in methicillin resistant Staphylococcus aureus alarming bell for vancomycin abusers?


Department of Microbiology, Grant Medical College & Sir J. J. Group of Hospitals, Byculla, Mumbai 400 008, India

Date of Submission12-Feb-2010
Date of Acceptance14-May-2010
Date of Web Publication20-Oct-2010

Correspondence Address:
C Chande
Department of Microbiology, Grant Medical College & Sir J. J. Group of Hospitals, Byculla, Mumbai 400 008
India
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/0255-0857.71810

Rights and Permissions



How to cite this article:
Veer P, Chande C, Chavan S, Wabale V, Chopdekar K, Bade J, Joshi A. Increasing levels of minimum inhibitory concentration vancomycin in methicillin resistant Staphylococcus aureus alarming bell for vancomycin abusers?. Indian J Med Microbiol 2010;28:413-4

How to cite this URL:
Veer P, Chande C, Chavan S, Wabale V, Chopdekar K, Bade J, Joshi A. Increasing levels of minimum inhibitory concentration vancomycin in methicillin resistant Staphylococcus aureus alarming bell for vancomycin abusers?. Indian J Med Microbiol [serial online] 2010 [cited 2019 Sep 22];28:413-4. Available from: http://www.ijmm.org/text.asp?2010/28/4/413/71810


Dear Editor,

Increasing minimum inhibitory concentration of an antimicrobial for a bacterium is the marker of future resistance of the organism to that antibiotic. [1] Vancomycin is the drug of choice for the infections caused by methicillin resistant Staphylococcus aureus (MRSA) and often used empirically for the patients in critical-care settings with infections like severe sepsis, pneumonias and those under umbilical catheterization etc in India. The presence of vancomycin pressure is likely to increase the selection of resistant strains. Recovery of clinical isolates of vancomycin resistant S. aureus from outside India is reported. [2],[3] Emergence of low level vancomycin resistance has already been reported from India. [4] Continuous surveillance is therefore required to monitor the emergence of vancomycin -intermediate Staphylococcus aureus (VISA) and vancomycin resistant Staphylococcus aureus (VRSA) strains. When the susceptibility levels for vancomycin in MRSA strains (identified using 30 μg cefoxitin discs) that were recovered during January 2008 to June 2009 was assessed, [5] it was observed that in 77 isolates recovered from blood and pus specimens, as many as 31 (40.25%) isolates had MIC 4μg/ml by agar dilution method. As per the Clinical and Laboratory Standard Institute (CLSI) guidelines of 2008, strains with MIC of 4 to 8 μg/ml should be categorized as VISA strains. None of these isolates grew on vancomycin screen brain heart infusion agar plate with vancomycin 6 μg/ml. All the isolates were sensitive to vancomycin by disc diffusion test using 30μg vancomycin disc. Though none of the isolates had MIC ≥16 μg/ml, the high level of MIC in the sensitive strains is definitely alarming considering the therapeutic consequences of vancomycin resistance in S. aureus. The strains showed 100% sensitivity to linezolid and rifampicin and 31% and 35% susceptibility to cotrimoxazole and clindamycin respectively. The increasing MICs of S. aureus isolates to vancomycin are an alarming bell for the users as the strains with reduced susceptibility could be the harbinger of future strains with full-blown resistance. In view of the limited therapeutic options for the treatment of MRSA infections, prudent use of vancomycin, continuous surveillance for VISA and VRSA strains and appropriate infection control practices for the prevention of spread of such strains in the hospital environment are strongly recommended.

 
 ~ References Top

1.Levy SB. Multidrug resistance-a sign of the times. N Engl J Med 1998;338:1376-8.  Back to cited text no. 1  [PUBMED]  [FULLTEXT]  
2.Smith TL, Pearson ML, Wilcox KR, Cruz C, Lancaster MV, Robinson-Dunn B, et al. Emergence of vancomycin resistance in Staphylococcus aureus. N Eng J Med 1999;340:493-501.  Back to cited text no. 2      
3.Chang S, Sievert DM, Hageman JC, Boulton ML, Tenover FC, Downes FP, et al. Infection with Vancomycin-Resistant Staphylococcus aureus containing the vanA resistance gene. N Eng J Med 2003;348:1342-7.  Back to cited text no. 3      
4.Assadullah S, Kakru DK, Thoker MA, Bhat FA, Hussain N, Shah A. Emergence of low level Vancomycin resistance in MRSA. Indian J Med Microbiol 2009;21:196-8.  Back to cited text no. 4      
5.Clinical and Laboratory Standard Institute (CLSI): Performance standards for antimicrobial susceptibility testing. 18 th International Supplement. CLSI document M 100-18, Wayne, Pennsylvania, 2008.  Back to cited text no. 5      



This article has been cited by
1 Vancomycin resistance among methicillin resistant Staphylococcus aureus isolates from intensive care units of tertiary care hospitals in Hyderabad
Thati, V., Shivannavar, C.T., Gaddad, S.M.
Indian Journal of Medical Research. 2011; 134(11): 704-708
[Pubmed]
2 Glycopeptides-Important treatment option for methicillin-resistant Staphylococcus aureus
Arora, S., Arora, U.
Indian Journal of Medical Microbiology. 2011; 29(3): 313
[Pubmed]



 

Top
Print this article  Email this article
Previous article Next article

    

2004 - Indian Journal of Medical Microbiology
Published by Wolters Kluwer - Medknow

Online since April 2001, new site since 1st August '04